US vaccine panel retreats from mRNA Covid review ahead of midterms
A US vaccine advisory panel has halted its review of mRNA Covid-19 vaccines, influenced by political concerns regarding the upcoming midterm elections.
Farewell to Sahin and Türeci: A Wise Decision by the BioNTech Founders
Ugur Sahin and Özlem Türeci, founders of BioNTech, are stepping back from daily operations, a decision viewed as part of their strategic foresight.
Biontech: 'Heart and Brain'
Uğur Şahin and Özlem Türeci, the co-founders of Biotech company Biontech, will step down from their executive roles at the end of 2026 to start a new venture focused on mRNA and AI.
The two founders of BioNTech leave the pharmaceutical company that won the race for COVID vaccines
The founders of BioNTech, Ugur Sahin and Özlem Türeci, are leaving the company to create a new venture focused on next-generation mRNA medications.
End of an Era at BioNTech: Turkish Co-Founders Depart
The co-founders of BioNTech, Ugur Sahin and Özlem Türeci, are leaving the company to pursue a new venture focusing on next-generation mRNA technology amid rising financial losses for BioNTech.
Pharmaceutical Industry: BioNTech Founders Leave Company
BioNTech founders Uğur Şahin and Özlem Türeci will leave the company by the end of 2026 to start a new biotechnology firm focused on developing the next generation of mRNA-based drugs, while remaining shareholders in BioNTech.
Pharmaceutical industry: BioNTech founders leave the company
BioNTech founders Uğur Şahin and Özlem Türeci will leave the company by the end of 2026 to establish a new biotechnology firm focused on mRNA-based medications while retaining a minority stake in BioNTech.
Pharma Pioneers: Founders Ugur Sahin and Özlem Türeci Leave Biontech
Biontech founders Ugur Sahin and Özlem Türeci are set to leave the company to start a new biopharmaceutical venture focusing on mRNA-based medications.
Anti-Covid Vaccines, Moderna Settles mRNA Technology Lawsuit: $2.25 Billion Agreement
Moderna has reached a $2.25 billion settlement to resolve a lawsuit regarding the use of mRNA technology developed by other companies for its Covid vaccine.
Diabetes breakthrough approach could protect cells and prevent disease
Researchers at the University of Chicago have developed an mRNA therapy that may prevent or slow the progression of type 1 diabetes by protecting insulin-producing cells.
After cuts, FDA chief supports mRNA vaccines but says government should not fund research
The FDA chief, Marty Makary, expresses support for mRNA vaccines while stating that American taxpayers shouldn't bear the costs of new research.
US agrees to review new Moderna flu vaccine
Moderna has announced that the FDA has reversed its decision and will analyze its new flu vaccine, which uses mRNA technology.
Hope Against Triple Negative Breast Cancer: Experimental Vaccine Shows Positive Results
An experimental mRNA vaccine shows promising outcomes in a small trial for triple-negative breast cancer patients.
FDA reverses course and will review Moderna’s mRNA-based flu vaccine
The FDA has decided to review Moderna's application for its mRNA-based flu vaccine after initially declining it, responding to criticism regarding its decision-making processes.
Geneticist Pačes: Kotlár's study on mRNA vaccines contains errors, it is very unlikely to be published in a serious journal
Czech molecular geneticist Jan Pačes critiques Peter Kotlár's analysis of mRNA vaccines, citing numerous errors and questioning its potential publication in credible scientific journals.
Personalized vaccine against triple-negative breast cancer could change treatment in Mexico
A new personalized mRNA vaccine being developed in Mexico may transform treatment for triple-negative breast cancer, a particularly aggressive subtype of the disease.
Leader: Because of Trump, there might be no vaccine for cancer
The article discusses how Donald Trump's political actions in the U.S. may impede the development of a promising cancer vaccine based on mRNA technology.
FDA refuses to consider Moderna flu shot in move experts claim is part of ‘anti-vaccine agenda’
The FDA declined to review Moderna's mRNA flu vaccine application, prompting concerns that the decision may be influenced by anti-vaccine sentiment rather than scientific rigor.
Slovak Government Commissioner Again Called for the End of mRNA Vaccination
A Slovak government official has reiterated calls to halt the use of mRNA vaccines amid ongoing health discussions.
Kotlár Informed the Government in Confidential Procedure / Drucker Heard Nothing Significant, Takáč Was Shocked by the Findings. A New Report for the Police Analyzed Peková's Analysis
A new expert report commissioned by the Slovak police confirms the effectiveness and safety of mRNA vaccines, contradicting claims made by Sona Peková regarding the presence of DNA in vaccines.
Accused Kotlár again demands the withdrawal of mRNA vaccines. The opposition SaS calls for a parliamentary investigation by the commissioner
Peter Kotlár, a commissioner and member of the SNS party, demands the withdrawal of mRNA vaccines citing new findings, despite lacking transparency and evidence for his claims.
Moderna claims that the US refuses to review the mRNA-based flu vaccine
Moderna asserts that the US FDA has declined to review its mRNA-based flu vaccine due to concerns over inadequate clinical trials and lack of proper comparison with existing products.
FDA refuses to review Moderna’s mRNA flu vaccine application
The FDA has declined to review Moderna's mRNA flu vaccine application, potentially delaying its introduction for older adults.
FDA declines to review Moderna application for new flu vaccine
US regulators have refused to review Moderna's request for a new flu vaccine, raising concerns about the future of flu vaccination efforts in the country.
Mexico signs agreement with laboratories to produce vaccines against Covid, dengue, and cancer
President Claudia Sheinbaum announced a partnership to produce mRNA vaccines in Mexico, involving the Health Secretary, Birmex, and pharmaceutical companies Liomont and Moderna.
Great Expectations for Vaccine Against Advanced Lung Cancer: What the Director of St. Savvas Oncology Says
The director of St. Savvas Oncology, Alexandros Ardavani, expresses optimism regarding an mRNA therapeutic vaccine currently undergoing trials for advanced lung cancer.
mRNA vaccines and myocarditis. New data on the cause
A new study aims to address the gap in understanding the immune response leading to rare myocarditis cases following mRNA COVID-19 vaccinations.
Patents: Bayer sues Biontech and Pfizer over COVID vaccines
Bayer is suing Pfizer, Biontech, and Moderna for potential patent violations related to their mRNA vaccines, claiming they copied technology from Bayer's subsidiary, Monsanto.